A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age
Clinical trial NCT06222892 · COMPLETED
Trial details
- NCT number
- NCT06222892
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-02
- Primary completion
- 2024-12-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.